Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Current Leases: 2022-2025

Historic Current Leases for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to $9,048.

  • Addex Therapeutics' Current Leases fell 33.97% to $9,048 in Q2 2025 from the same period last year, while for Jun 2025 it was $9,048, marking a year-over-year decrease of 33.97%. This contributed to the annual value of $8,305 for FY2024, which is 97.28% down from last year.
  • Addex Therapeutics' Current Leases amounted to $9,048 in Q2 2025, which was up 9.96% from $8,228 recorded in Q1 2025.
  • Addex Therapeutics' Current Leases' 5-year high stood at $316,292 during Q1 2022, with a 5-year trough of $8,228 in Q1 2025.
  • Moreover, its 3-year median value for Current Leases was $13,863 (2024), whereas its average is $86,540.
  • As far as peak fluctuations go, Addex Therapeutics' Current Leases increased by 3.99% in 2023, and later tumbled by 97.30% in 2024.
  • Over the past 4 years, Addex Therapeutics' Current Leases (Quarterly) stood at $296,985 in 2022, then climbed by 3.99% to $308,846 in 2023, then crashed by 97.30% to $8,340 in 2024, then tumbled by 33.97% to $9,048 in 2025.
  • Its last three reported values are $9,048 in Q2 2025, $8,228 for Q1 2025, and $8,340 during Q4 2024.